sar425899 sanofi glp-1 glucagon dual agonist agonism in the treatment of metabolic diseases including type 2 diabetes mellitus and obesity - Winther - 2024 - Diabetes, Obesity and Metabolism Role of a Dual Glucose-Dependent
Description
tested human duct cells and demonstrated that exenatide was associated with increased phosphorylation of certain mitogen-activated kinases 18
10.1056/NEJMoa1509225 49
The cheapest GLP-1 medication is Rybelsus, which is available in oral form for the treatment of type 2 diabetes
Proc Natl Acad Sci U S A (2003) 100(9):50638
There's still plenty more to come this week (assuming I don't get completely lost in The Venetian), so make sure you're keeping up with CNBC's coverage
[2] Drucker, D
